COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications
Open Access
- 5 October 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 113, 103-108
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Global drug shortages due to COVID-19: Impact on patient care and mitigation strategiesResearch in Social and Administrative Pharmacy, 2021
- Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building ProgramsCurrent Infectious Disease Reports, 2020
- Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries: A position statement for the international society for infectious diseasesInternational Journal of Infectious Diseases, 2020
- Antimicrobial stewardship interventions to minimize healthcare worker exposure to SARS-CoV-2Infection Control & Hospital Epidemiology, 2020
- Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 PandemicJournal of Medical Systems, 2020
- Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patientsInfection Control & Hospital Epidemiology, 2020
- Nationwide survey of pharmacists’ involvement in antimicrobial stewardship programs in Nigerian tertiary hospitalsJournal of Global Antimicrobial Resistance, 2020
- Deaths from COVID-19 in healthcare workers in Italy—What can we learn?Infection Control & Hospital Epidemiology, 2020
- Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deckInfection Control & Hospital Epidemiology, 2020
- An international cross-sectional survey of antimicrobial stewardship programmes in hospitalsJournal of Antimicrobial Chemotherapy, 2014